aaiPharma Situation Underscores The Need for Due Diligence

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-02-2004
Volume 28
Issue 5

Sponsors who have been lax in performing financial due diligence on their contractors have been given a wake-up call by the recent developments at aaiPharma.

Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
CPHI Milan 2024: Highlighting the Benefits of Integrated Services